Core Viewpoint - Lin Qingxuan has officially listed on the Hong Kong Stock Exchange, becoming the first high-end domestic skincare brand in the Hong Kong market, focusing on anti-wrinkle and firming skincare products with a commitment to quality and supply chain control [1][2]. Group 1: Company Overview - Lin Qingxuan specializes in high-end skincare products, particularly in the anti-wrinkle and firming segment, utilizing natural camellia flower as a core ingredient [1]. - The company has established a complete value chain from seedling cultivation to production and sales, ensuring product quality and stable supply [1]. - As of 2024, Lin Qingxuan ranks first among domestic high-end skincare brands and is the only domestic representative among China's top 15 high-end skincare brands [1]. Group 2: Financial Performance - From 2022 to 2024, Lin Qingxuan's revenue is projected to grow from 690 million to 1.21 billion, with a compound annual growth rate of 32.3% [2]. - In the first half of 2025, revenue surged by 98.3% year-on-year, reaching 1.052 billion, while adjusted net profit increased by 117.4% to 200 million [2]. Group 3: Industry Impact and Future Outlook - Lin Qingxuan's listing is seen as a catalyst for the high-end transformation of domestic beauty brands, encouraging more brands to enhance their R&D and establish core technologies [2]. - The company plans to use the funds raised from the IPO to improve production efficiency, advance global branding, and digital transformation, aiming for sustained high growth and international recognition [3]. - The founder emphasizes ongoing investment in dermatology, botany, and cutting-edge skincare technology, alongside brand development and retail expansion to enhance customer experience and shareholder value [3].
国货护肤品牌林清轩登陆港交所 以技术驱动高端化布局